High Times

 Companies are selling saliva kits so customers can figure out the best marijuana strain and get HIGH

                            

As marijuana continues to become legal across the US, a burgeoning industry is popping up that will let customers figure out the right strain and dose via their DNA to stave off bad trips and help with ailments.

Companies such as Endocanna Health have created saliva kits that look for genetic traits, akin to 23andMe, but for marijuana.

Endocanna's test looks at 57 genetic traits to see how a person responds to marijuana.

Companies are creating at-home tests to let customers figure out the right strain and dose of marijuana to buy via their DNA

Endocanna's $ 199 at-home test looks at 57 genetic traits to see how a person responds to marijuana

The $ 199 kit looks for 57 different traits in 12 different categories, offering a 'personalized wellness plan' and and 'Endo · Aligned cannabinoid formulation suggestions,' according to the company’s website . 

Once users register on the mydna.live website, they can spit their saliva onto a swab they then return in a prepaid mailer that comes with the DNA kit. 

The company then analyzes the swab and uploads a personalized report that offers a formula suggestion for the right strain and dose of marijuana. 

Just over 31% of US adults suffer from anxiety and 90% percent of people with general anxiety disorder have symptoms of another mental health problem

'Your DNA is your blueprint,' Endocanna Health CEO Len May said in an interview with Bloomberg .   

'It gives you a GPS that can guide you to an experience that is more optimal and helps you avoid sharp corners.'  

The 18 locales (17 states and the District of Columbia) in black have fully legalized marijuana. In total, 43 states and the District of Columbia have varying degrees of legalization of cannabis

In total, 43 states and the District of Columbia have varying degrees of legalization of cannabis.

Just over 31 percent of US adults suffer from anxiety and 90 percent of people with general anxiety disorder have symptoms of another mental health problem, according to data from the National Institute of Mental Health. 

A study published in May found that 9 out of 10 patients that took MDMA, also known as 'molly,' saw a significant reduction in PTSD symptoms after three therapy sessions, compared to 6 in 10 that used a placebo